Discure Technologies

Discure Technologies
Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.
About
Technology stack
detected 2026-07-07No comments yet. Be the first to share your take.
What does Discure Technologies do?
Discure Technologies develops a minimally invasive, implantable device designed to treat and reverse degenerative disc disease by restoring the disc's healthy fluid dynamics. This approach aims to restore cushioning, stability, revive disc cells, and accelerate healing to reduce pain and restore function for individuals suffering from back pain. The company serves patients experiencing back pain due to disc degeneration and collaborates with hospitals, universities, and healthcare companies.
How much funding has Discure Technologies raised?
Discure Technologies has raised a total of $11M in funding. The most recent round on record is Series A.
Where is Discure Technologies headquartered?
Discure Technologies is headquartered in Tel Aviv, Israel.
When was Discure Technologies founded?
Discure Technologies was founded in 2021.
What industry does Discure Technologies operate in?
Discure Technologies operates in Healthcare, Patient Care, Life Sciences, Medical Devices, MedTech, HealthTech.
How many employees does Discure Technologies have?
Discure Technologies has approximately 12 people on record.
What is Discure Technologies's revenue?
StartupHub estimates Discure Technologies's annual revenue at $3.8M (range $2.1M to $6.1M, 63% confidence), based on comparable companies in the sector.
What is Discure Technologies's valuation?
StartupHub estimates Discure Technologies's effective valuation at $44.2M (range $27.5M to $66.0M, 16% confidence), based on comparable companies in the sector.